Open Therapeutics and AuthorAID to Cooperate on Advancing Scientific Knowledge

Share Article

The unique scientific collaboration will help underserved scientists around the world communicate break-through therapeutic biotechnology research.

Open Therapeutics™ (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global scientific community.

Open Therapeutics™

“AuthorAID has aproven ability to deliver a mentorship and educational program to underserved scientists," says Jason Barkeloo, founder and executive chairman of Open Therapeutics.

Open Therapeutics and INASP’s AuthorAID project announce the formation of a unique scientific collaboration for helping underserved scientists around the world communicate break-through therapeutic biotechnology research.

The partnership will provide scientific researchers an ability to conduct or receive mentorship, educational materials, and grant funding.

AuthorAID is a pioneering global network that provides support, mentoring, resources and training for researchers from low and middle income countries. The programme supports over 16,000 researchers to publish and communicate their work by providing free access to mentoring, online courses in research and proposal writing,training resources, and a global network of supporters.

Open Therapeutics helps underserved researchers around the world gain scientific collaborators. This is done by crowdsourcing the researchers around open therapeutic biotechnologies within its free web-based collaboration platform, Therapoid™.

According to Jason E. Barkeloo, Founder and Executive Chairman of Open Therapeutics, “AuthorAID has a proven ability to deliver a mentorship and educational program to underserved scientists. We are proud to offer the AuthorAID program to collaborating scientists within Therapoid. We are also excited to help the researchers within Therapoid learn about communicating their scientific findings to other researchers, journals, and grant funders.”

Jennifer Chapin, AuthorAID Program Manager at INASP, outlines how AuthorAID and Open Therapeutics complement each other: “We are looking forward to connecting our researchers with the innovative offers on the Therapoid platform, and we know that this partnership will create a richer breadth of services for researchers from developing countries looking to build skills, publish and progress in their careers.”

About Open Therapeutics LLC
Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global scientific community. The global research community can freely access the biotechnologies and funding to further the development of the biotechnologies at Therapoid™ (https://Therapoid.net). The Company is headquartered in Minneapolis, MN, with laboratory operations in Covington, Kentucky, Cincinnati, OH, Amman, Jordan, and Bangalore, India.

Contact: Jerome Hamilton, CEO, Open Therapeutics
+1 (651) 900-0412
OpenTherapeutics.org
@OpenTherapeutic

About AuthorAID
AuthorAID (http://www.authoraid.info) was launched in 2007 by Oxford-based organization INASP (http://www.inasp.info) to support researchers in developing countries to publish and communicate their work. It serves as a global forum for researchers to discuss and disseminate research and now comprises a community of over 16,000 researchers from around the world. In addition to providing mentorship, resources and grant funding, AuthorAID also runs massive open online courses (MOOCs) routinely attracting over 3,000 participants, and works locally with institutions in Africa and Asia to institutionalize training in research writing and in better supporting women researchers.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

MARICE SOMERVILLE

Jerome Hamilton
Visit website